Bio-Path Holdings, Inc.
BPTHOTCHealthcare● Active
$0.03
$-0.00(-8.57%)
Market Cap$298949
P/E Ratio—
52W High$0.23
52W Low$0.01
Bio-Path Holdings, Inc. (BPTH) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BPTH · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 20, 2026EPS Actual
-$0.03
Est. -$0.40 · +92.5%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 20, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
BPTH reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 18, 2026 | — | — | — | — | — | — |
| ◌ Q3 FY2026 | Aug 18, 2026 | — | — | — | — | — | — |
| ▲ Q2 FY2026 | May 20, 2026 | -$0.40 | -$0.03 | +92.5% | — | — | — |
| ▲ Q1 FY2026 | Jan 13, 2026 | -$0.40 | -$0.11 | +72.5% | — | — | — |
| ▼ Q3 FY2025 | Aug 14, 2025 | -$0.40 | -$0.55 | -37.5% | — | — | — |
| ▼ Q2 FY2025 | May 15, 2025 | -$0.38 | -$0.40 | -5.3% | — | — | — |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$0.37 | -$0.07 | +81.1% | $0.00B | — | — |
| ▲ Q4 FY2024 | Nov 14, 2024 | -$1.02 | -$0.87 | +14.7% | — | — | — |
Q3 FY2026
Aug 18, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2026
Aug 18, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 20, 2026Beat
EPS Actual
-$0.03
EPS Est.
-$0.40
EPS Surpr.
+92.5%
Revenue
—
Q1 FY2026
Jan 13, 2026Beat
EPS Actual
-$0.11
EPS Est.
-$0.40
EPS Surpr.
+72.5%
Revenue
—
Q3 FY2025
Aug 14, 2025Miss
EPS Actual
-$0.55
EPS Est.
-$0.40
EPS Surpr.
-37.5%
Revenue
—
Q2 FY2025
May 15, 2025Miss
EPS Actual
-$0.40
EPS Est.
-$0.38
EPS Surpr.
-5.3%
Revenue
—
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
-$0.07
EPS Est.
-$0.37
EPS Surpr.
+81.1%
Revenue
$0.00B
Q4 FY2024
Nov 14, 2024Beat
EPS Actual
-$0.87
EPS Est.
-$1.02
EPS Surpr.
+14.7%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.40 | $-0.40 | $-0.40 | 1 |
| Q3 FY2025 | $-0.40 | $-0.40 | $-0.40 | 1 |
| Q2 FY2025 | $-0.40 | $-0.40 | $-0.40 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 20, 2026 | +92.5% | $0.02 | $0.03 | +34.01% |
| ▲ Q1 FY2026 | Jan 13, 2026 | +72.5% | $0.05 | $0.05 | -5.47% |
| ▼ Q3 FY2025 | Aug 14, 2025 | -37.5% | $0.14 | $0.14 | -1.79% |
| ▼ Q2 FY2025 | May 15, 2025 | -5.3% | $0.18 | $0.18 | +0.00% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +81.1% | $0.16 | $0.17 | +6.25% |
| ▲ Q4 FY2024 | Nov 14, 2024 | +14.7% | $0.88 | $0.90 | +2.27% |
| ▲ Q3 FY2024 | Aug 15, 2024 | +24.7% | $1.51 | $1.49 | -1.32% |
| ▼ Q2 FY2024 | May 15, 2024 | -7.5% | $2.58 | $2.24 | -13.18% |
Q2 FY2026+34.01%
Report Date
May 20, 2026
EPS Beat/Miss
+92.5%
Price Before
$0.02
Price After
$0.03
Q1 FY2026-5.47%
Report Date
Jan 13, 2026
EPS Beat/Miss
+72.5%
Price Before
$0.05
Price After
$0.05
Q3 FY2025-1.79%
Report Date
Aug 14, 2025
EPS Beat/Miss
-37.5%
Price Before
$0.14
Price After
$0.14
Q2 FY2025+0.00%
Report Date
May 15, 2025
EPS Beat/Miss
-5.3%
Price Before
$0.18
Price After
$0.18
Q1 FY2025+6.25%
Report Date
Mar 27, 2025
EPS Beat/Miss
+81.1%
Price Before
$0.16
Price After
$0.17
Q4 FY2024+2.27%
Report Date
Nov 14, 2024
EPS Beat/Miss
+14.7%
Price Before
$0.88
Price After
$0.90
Q3 FY2024-1.32%
Report Date
Aug 15, 2024
EPS Beat/Miss
+24.7%
Price Before
$1.51
Price After
$1.49
Q2 FY2024-13.18%
Report Date
May 15, 2024
EPS Beat/Miss
-7.5%
Price Before
$2.58
Price After
$2.24
Avg Beat Reaction+7.15%
Avg Miss Reaction-4.99%
Beat Rate5 / 8 quarters
Largest Move+34.01% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BPTH ends December
Bio-Path Holdings, Inc. (BPTH) most recently reported earnings on May 20, 2026 for Q2 FY2026, posting EPS of $-0.03 — beating the analyst consensus of $-0.40 by +92.5%. BPTH has beaten EPS estimates for 2 consecutive quarters. The next BPTH earnings date is expected around September 1, 2026.
Each quarter, investors track BPTH earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BPTH revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BPTH's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BPTH earnings · 5 questionsBio-Path Holdings, Inc.'s next earnings report is expected around September 1, 2026. BPTH typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BPTH historically reports after market close (AMC).
BPTH earnings datewhen is BPTH earningsBPTH next earnings datewhen does BPTH report earningsBPTH earnings calendar
▸ Source: FMP · Bio-Path Holdings, Inc. SEC filings · US GAAP · Bio-Path Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026